These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 26546628)
1. Severe ischemic stroke: Too severe for thrombolysis? Uyttenboogaart M; Fink JN Neurology; 2015 Dec; 85(24):2088-9. PubMed ID: 26546628 [No Abstract] [Full Text] [Related]
2. IV thrombolysis in very severe and severe ischemic stroke: Results from the SITS-ISTR Registry. Mazya MV; Lees KR; Collas D; Rand VM; Mikulik R; Toni D; Wahlgren N; Ahmed N Neurology; 2015 Dec; 85(24):2098-106. PubMed ID: 26546630 [TBL] [Abstract][Full Text] [Related]
12. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time. Minnerup J; Wersching H; Ringelstein EB; Schilling M; Schäbitz WR; Wellmann J; Berger K Stroke; 2011 Oct; 42(10):2838-43. PubMed ID: 21852612 [TBL] [Abstract][Full Text] [Related]
13. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours. Thomalla G; Sobesky J; Köhrmann M; Fiebach JB; Fiehler J; Zaro Weber O; Kruetzelmann A; Kucinski T; Rosenkranz M; Röther J; Schellinger PD Stroke; 2007 Feb; 38(2):313-8. PubMed ID: 17204683 [TBL] [Abstract][Full Text] [Related]
14. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator. Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898 [TBL] [Abstract][Full Text] [Related]
15. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis. Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509 [TBL] [Abstract][Full Text] [Related]
16. Intra-arterial thrombolysis: tissue plasminogen activator and other thrombolytic agents. Samaniego EA; Linfante I; Dabus G Tech Vasc Interv Radiol; 2012 Mar; 15(1):41-6. PubMed ID: 22464301 [TBL] [Abstract][Full Text] [Related]
17. Failed recovery from thrombolysis is predicted by the initial diffusion weighted imaging lesion. Seitz RJ; Oberstrass H; Ringelstein A; Wittsack HJ; Siebler M Cerebrovasc Dis; 2011; 31(6):580-7. PubMed ID: 21487223 [TBL] [Abstract][Full Text] [Related]
18. Intravenous recombinant tissue plasminogen activator for acute stroke in Poland: an analysis based on the Safe Implementation of Thrombolysis in Stroke (SITS) Registry. Kobayashi A; Czlonkowska A; Ahmed N; Romanowicz S; Glonek M; Nyka WM; Opala G; Wahlgren N; Acta Neurol Scand; 2010 Oct; 122(4):229-36. PubMed ID: 19919643 [TBL] [Abstract][Full Text] [Related]
19. Intravenous thrombolysis for patients with ischaemic stroke on antiplatelet therapy: a blessing in disguise? Uyttenboogaart M; Luijckx GJ Eur J Neurol; 2010 Feb; 17(2):177-8. PubMed ID: 19922454 [No Abstract] [Full Text] [Related]